Literature DB >> 15610236

ANCA-induced neutrophil F-actin polymerization: implications for microvascular inflammation.

Wai Y Tse1, Gerard B Nash, Peter Hewins, Caroline O S Savage, Dwomoa Adu.   

Abstract

BACKGROUND: The antineutrophil cytoplasmic antibody (ANCA)-positive vasculitides are characterized by a necrotizing vasculitis of small vessels with neutrophil infiltration. The reasons behind the selectivity for small vessels remain unclear, but may relate to the necessity for neutrophils to deform in order to pass through capillaries. The resistance to deformation of neutrophils largely arises from their actin cytoskeleton. It is hypothesized that ANCA, by inducing actin polymerization, increases neutrophil rigidity and contributes to their sequestration in capillaries.
METHODS: To test this hypothesis, neutrophils were treated with IgG-ANCA and the following characterizations: formation of filamentous F-actin (by flow cytometry); changes in morphology (by fluorescence and electron microscopy); and the potential to obstruct microvessels (by measuring entry times into micropipettes with comparable diameters to capillaries). The neutrophil signaling mechanisms activated by IgG-ANCA were investigated using blocking antibodies to Fcgamma receptors and inhibitors of tyrosine phosphorylation. Protein tyrosine phosphorylation was examined by immunoblotting of cell lysates, and calcium fluxes were measured by spectrofluorimetry of Fura-2 pentakis (acetoxymethyl) ester (Fura 2-AM) labeled neutrophils.
RESULTS: IgG-ANCA led to a significant dose-dependent actin polymerization over about 10 minutes. Over the same period, neutrophils became distorted in shape and more resistant to micropipette aspiration. Treatment with normal IgG caused less marked and delayed changes in these parameters. Actin polymerization required engagement of FcgammaRIIa receptor, tyrosine phosphorylation, and calcium fluxes.
CONCLUSION: These novel findings reveal signaling mechanisms that underlie ANCA-induced actin polymerization and might explain the predilection for small vessels in IgG-ANCA-associated vasculitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15610236     DOI: 10.1111/j.1523-1755.2005.00063.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.

Authors:  David R W Jayne; Annette N Bruchfeld; Lorraine Harper; Matthias Schaier; Michael C Venning; Patrick Hamilton; Volker Burst; Franziska Grundmann; Michel Jadoul; István Szombati; Vladimír Tesař; Mårten Segelmark; Antonia Potarca; Thomas J Schall; Pirow Bekker
Journal:  J Am Soc Nephrol       Date:  2017-04-11       Impact factor: 10.121

2.  Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo.

Authors:  Sarah L Nolan; Neena Kalia; Gerard B Nash; Dia Kamel; Peter Heeringa; Caroline O S Savage
Journal:  J Am Soc Nephrol       Date:  2008-02-27       Impact factor: 10.121

Review 3.  Endothelium-neutrophil interactions in ANCA-associated diseases.

Authors:  Lise Halbwachs; Philippe Lesavre
Journal:  J Am Soc Nephrol       Date:  2012-09       Impact factor: 10.121

Review 4.  Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides.

Authors:  Ora Shovman; Boris Gilburd; Gisele Zandman-Goddard; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 5.  Mechanisms of vascular damage in ANCA vasculitis.

Authors:  David Massicotte-Azarniouch; Carolina A Herrera; J Charles Jennette; Ronald J Falk; Meghan E Free
Journal:  Semin Immunopathol       Date:  2022-03-07       Impact factor: 11.759

Review 6.  Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update.

Authors:  José A Gómez-Puerta; Xavier Bosch
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

7.  Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis.

Authors:  Renate Kain; Markus Exner; Ricarda Brandes; Reinhard Ziebermayr; Dawn Cunningham; Carol A Alderson; Agnes Davidovits; Ingrid Raab; Renate Jahn; Oliver Ashour; Susanne Spitzauer; Gere Sunder-Plassmann; Minoru Fukuda; Per Klemm; Andrew J Rees; Dontscho Kerjaschki
Journal:  Nat Med       Date:  2008-10-05       Impact factor: 53.440

8.  Modulating the Adhesion of Haematopoietic Stem Cells with Chemokines to Enhance Their Recruitment to the Ischaemically Injured Murine Kidney.

Authors:  Rebecca L White; Gerard Nash; Dean P J Kavanagh; Caroline O S Savage; Neena Kalia
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

9.  Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 Trial.

Authors:  Peter A Merkel; David R Jayne; Chao Wang; Jan Hillson; Pirow Bekker
Journal:  JMIR Res Protoc       Date:  2020-04-07

10.  Designing Microfluidic Devices to Sort Haematopoietic Stem Cells Based on Their Mechanical Properties.

Authors:  Mingming Du; Dean Kavanagh; Zhibing Zhang; Neena Kalia
Journal:  Stem Cells Int       Date:  2019-09-05       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.